Skip to main content

On This Page

← AI Financial News

Legence Corp. – 2025-11-18 - increase Confidence 8/10

2 min read $LGN
Share

These articles are AI-generated summaries. Please check the original sources for full details.

LGNLegence Corp.
$33.32+2.82 (+9.25%)
$42$36$30Sep 12Oct 14Nov 13
52W High: $41.5452W Low: $29.72Volume: 641.30K
NMS
Prediction (12/2/2025):High: $45.63Low: $26.96Ref Price: $44.93
This chart shows historical data as of November 13, 2025. Not updated in real-time.

LGN – increase in Days/Weeks

Free cash flow of $10.26 million contrasts with a sky-high debt/equity ratio of 993.56, yet recent IPO proceeds have slashed net debt to $650 million. Q3 revenue surged 26% YoY to $708 million, paired with a record $3.1 billion backlog and a 1.5x book-to-bill ratio.

Why This Matters

The company is transitioning from a leveraged private entity to a publicly traded growth story, with fundamental momentum now aligned with improved capital structure—backlog growth in mission-critical infrastructure sectors like data centers and semiconductors reflects strong demand tailwinds, while the IPO and credit facility repricing have alleviated near-term refinancing risks, making the stock more attractive for momentum investors.

Key Insights

  • Revenue & Backlog: Revenue +26% YoY, backlog up 29% to $3.1B with 1.5x book-to-bill, Q3 2025
  • News Impact: IPO raised $780M + debt reduction + acquisition spree (AZPE, IMD, Bowers) → scale and integration upside
  • Risk/Offset: Forward P/E of 52.3 is steep; valuation hinges on 2026 EBITDA guidance ($295–315M) being met

Practical Implications

  • Bull Case: Beat-and-raise Q4 earnings + Bowers integration signal → move toward 52-week high ($45.63) in 2–3 weeks
  • Bear Case: High forward P/E leaves little room for miss; any guidance caution could trigger 5–7% pullback
  • Confidence: 8/10 – Strong fundamentals, improving balance sheet, and institutional ownership provide near-term support

Prediction: increase

Reference:

Continue reading

Next article

Jyong Biotech Ltd. – 2025-11-18 - increase Confidence 6/10

Previous Analysis for $LGN

Related Content